Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CARERATING.NS Stock Summary
Top 10 Correlated ETFs
CARERATING.NS
In the News
CARERATING.NS Financial details
Company Rating
Neutral
Market Cap
33.65B
Income
960.42M
Revenue
3.19B
Book val./share
-
Cash/share
-
Dividend
25
Dividend %
2.61%
Employees
517
Optionable
No
Shortable
Yes
Earnings
04 Apr 2024
P/E
32.18
Forward P/E
25.44
PEG
11.92
P/S
9.43
P/B
4.17
P/C
-
P/FCF
5908.95
Quick Ratio
6.52
Current Ratio
7.48
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
32.32
EPS next Y
44
EPS next Q
-
EPS this Y
10.69%
EPS next Y
36.14%
EPS next 5Y
-4.08%
EPS last 5Y
-9.6%
Revenue last 5Y
-2.64%
Revenue Q/Q
-18.42%
EPS Q/Q
-33.39%
-
-
-
-
SMA20
-4.71%
SMA50
16.08%
SMA100
26.22%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
26%
ROC
0.18%
Gross Margin
50%
Oper. Margin
43%
Profit Margin
29%
Payout
-
Shs Outstand
29.84M
Shs Float
26.01M
-
-
-
-
Target Price
-
52W Range
610.15-1263.95
52W High
-11.37%
52W Low
+83.51%
RSI
52
Rel Volume
0.28
Avg Volume
94.95K
Volume
26.16K
Perf Week
0.43%
Perf Month
2.04%
Perf Quarter
30.76%
Perf Half Y
30.28%
-
-
-
-
Beta
1.247
-
-
Volatility
13.29%, 32.55%
Prev Close
-1.51%
Price
1119.4
Change
0.85%
CARERATING.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 108.27 | 82.7 | 81.17 | 83.69 | 94.08 | |
Net income per share | 46.66 | 27.96 | 30.38 | 25.45 | 28.17 | |
Operating cash flow per share | 36.85 | -10.12 | 29.25 | 23.04 | 27.73 | |
Free cash flow per share | 27.95 | -11.67 | 27.73 | 16.61 | 23.85 | |
Cash per share | 74.23 | 76.56 | 165.06 | 177.06 | 190.44 | |
Book value per share | 186.68 | 181.01 | 199.86 | 219.41 | 226.67 | |
Tangible book value per share | 184.29 | 178.95 | 197.41 | 215.62 | 224.2 | |
Share holders equity per share | 186.68 | 181.01 | 199.86 | 219.41 | 226.67 | |
Interest debt per share | -6.92 | 4.12 | 2.66 | 3.18 | 6.23 | |
Market cap | 29.32B | 9.64B | 12.11B | 15.06B | 19.06B | |
Enterprise value | 29.12B | 9.69B | 12.06B | 14.98B | 18.74B | |
P/E ratio | 21.33 | 11.71 | 13.53 | 20.06 | 22.82 | |
Price to sales ratio | 9.19 | 3.96 | 5.06 | 6.1 | 6.83 | |
POCF ratio | 27.01 | -32.36 | 14.05 | 22.15 | 23.18 | |
PFCF ratio | 35.61 | -28.05 | 14.82 | 30.73 | 26.95 | |
P/B Ratio | 5.33 | 1.81 | 2.06 | 2.33 | 2.84 | |
PTB ratio | 5.33 | 1.81 | 2.06 | 2.33 | 2.84 | |
EV to sales | 9.13 | 3.98 | 5.04 | 6.06 | 6.72 | |
Enterprise value over EBITDA | 17.92 | 9.91 | 10.17 | 14.02 | 13.11 | |
EV to operating cash flow | 26.82 | -32.5 | 14 | 22.02 | 22.79 | |
EV to free cash flow | 35.36 | -28.17 | 14.77 | 30.55 | 26.5 | |
Earnings yield | 0.05 | 0.09 | 0.07 | 0.05 | 0.04 | |
Free cash flow yield | 0.03 | -0.04 | 0.07 | 0.03 | 0.04 | |
Debt to equity | -0.04 | 0.02 | 0.01 | 0.01 | 0.03 | |
Debt to assets | -0.03 | 0.02 | 0.01 | 0.01 | 0.02 | |
Net debt to EBITDA | -0.12 | 0.04 | -0.04 | -0.08 | -0.22 | |
Current ratio | 5.71 | 4.95 | 10.34 | 11.01 | 10.19 | |
Interest coverage | 0 | 79.3 | 142.46 | 155.49 | 94.36 | |
Income quality | 0.54 | -0.29 | 0.73 | 0.69 | 0.65 | |
Dividend Yield | 0.07 | 0.11 | 0.03 | 0.03 | 0.03 | |
Payout ratio | 1.42 | 1.25 | 0.44 | 0.51 | 0.72 | |
Sales general and administrative to revenue | 0.01 | 0.04 | 0.04 | 0.04 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0.02 | 0.03 | 0.03 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.24 | 0.15 | -0.05 | -0.28 | -0.14 | |
Capex to revenue | -0.08 | -0.02 | -0.02 | -0.08 | -0.04 | |
Capex to depreciation | -7.87 | -0.59 | -0.56 | -2.46 | -1.09 | |
Stock based compensation to revenue | 0.04 | 0.02 | 0.01 | 0.03 | 0 | |
Graham number | 442.71 | 337.44 | 369.64 | 354.47 | 379.01 | |
ROIC | 0.22 | 0.11 | 0.11 | 0.08 | 0.09 | |
Return on tangible assets | 0.23 | 0.14 | 0.14 | 0.11 | 0.11 | |
Graham Net | 34.9 | 43.15 | 117.82 | 162.79 | 167.58 | |
Working capital | 2.3B | 2.36B | 4.94B | 5.13B | 5.44B | |
Tangible asset value | 5.43B | 5.27B | 5.82B | 6.36B | 6.65B | |
Net current asset value | 2.17B | 2.14B | 4.68B | 4.89B | 5.11B | |
Invested capital | -0.04 | 0.02 | 0.01 | 0.01 | 0.03 | |
Average receivables | 276.83M | 547.02M | 488.73M | 435.28M | 431.37M | |
Average payables | 18.11M | 12.52M | 21.57M | 39.46M | 75.43M | |
Average inventory | -945.95M | -1.51B | -1.5B | -932.34M | -79.86M | |
Days sales outstanding | 63.36 | 80.95 | 66.71 | 64.07 | 56.16 | |
Days payables outstanding | 4.04 | 5.92 | 9.33 | 16.7 | 27.12 | |
Days of inventory on hand | -807.39 | -428.68 | -631.26 | 0 | -43.53 | |
Receivables turnover | 5.76 | 4.51 | 5.47 | 5.7 | 6.5 | |
Payables turnover | 90.3 | 61.68 | 39.11 | 21.86 | 13.46 | |
Inventory turnover | -0.45 | -0.85 | -0.58 | 1.12B | -8.39 | |
ROE | 0.25 | 0.15 | 0.15 | 0.12 | 0.12 | |
Capex per share | -8.9 | -1.55 | -1.52 | -6.43 | -3.88 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 20.96 | 26.12 | 22.38 | 32.44 | 26.43 | |
Net income per share | 5.38 | 6.61 | 6 | 11.83 | 7.88 | |
Operating cash flow per share | 1.8 | 0.16 | 1.73 | 1.77 | 1.75 | |
Free cash flow per share | 1.8 | 0.16 | 1.73 | 1.77 | 1.75 | |
Cash per share | 187.67 | 190.34 | 187.21 | 188.26 | 0 | |
Book value per share | 226.04 | 226.55 | 228.76 | 230.06 | 0 | |
Tangible book value per share | 0 | 224.08 | 0 | 227.26 | 0 | |
Share holders equity per share | 226.04 | 226.55 | 228.76 | 230.06 | 0 | |
Interest debt per share | 0.05 | 6.07 | 0.13 | 7.12 | 0.16 | |
Market cap | 17.99B | 19.07B | 20.85B | 26.07B | 27.83B | |
Enterprise value | 23.56B | 18.75B | 26.4B | 25.32B | 27.83B | |
P/E ratio | 28.2 | 24.32 | 29.26 | 18.53 | 29.66 | |
Price to sales ratio | 28.95 | 24.61 | 31.39 | 27.03 | 35.37 | |
POCF ratio | 337.81 | 3.95K | 405.16 | 495.2 | 534.21 | |
PFCF ratio | 337.81 | 3.95K | 405.16 | 495.2 | 534.21 | |
P/B Ratio | 2.68 | 2.84 | 3.07 | 3.81 | 0 | |
PTB ratio | 2.68 | 2.84 | 3.07 | 3.81 | 0 | |
EV to sales | 37.91 | 24.19 | 39.75 | 26.26 | 35.37 | |
Enterprise value over EBITDA | 79.96 | 47.59 | 89.91 | 47.69 | 75.14 | |
EV to operating cash flow | 442.27 | 3.88K | 513.17 | 480.97 | 534.21 | |
EV to free cash flow | 442.27 | 3.88K | 513.17 | 480.97 | 534.21 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.03 | 0 | 0.03 | 0 | |
Debt to assets | 0 | 0.02 | 0 | 0.03 | 0 | |
Net debt to EBITDA | 18.89 | -0.81 | 18.92 | -1.41 | 0 | |
Current ratio | 0 | 10.19 | 0 | 7.48 | 0 | |
Interest coverage | 192.81 | 67.59 | 40.1 | 124.24 | 73.43 | |
Income quality | 0.33 | 0.02 | 0.29 | 0.15 | 0.22 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.11 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.02 | 0 | 0.02 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 165.41 | 183.51 | 175.74 | 247.46 | 0 | |
ROIC | 0.03 | 0.03 | 0.02 | 0.05 | 0 | |
Return on tangible assets | 0 | 0.03 | 0 | 0.04 | 0 | |
Graham Net | 187.67 | 167.5 | 187.21 | 163.76 | 0 | |
Working capital | 5.56B | 5.44B | 5.56B | 5.56B | 0 | |
Tangible asset value | 0 | 6.65B | 0 | 6.76B | 0 | |
Net current asset value | 5.56B | 5.11B | 5.56B | 5.2B | 0 | |
Invested capital | 0 | 0.03 | 0 | 0.03 | 0 | |
Average receivables | 243.49M | 214.63M | 214.63M | 308.16M | 308.16M | |
Average payables | 38.17M | 49.76M | 49.76M | 54.37M | 54.37M | |
Average inventory | 32.84M | -79.87M | -79.87M | 31.76M | 31.76M | |
Days sales outstanding | 0 | 49.84 | 0 | 57.52 | 0 | |
Days payables outstanding | 0 | 24.09 | 0 | 24.19 | 0 | |
Days of inventory on hand | 0 | -38.66 | 0 | 14.13 | 0 | |
Receivables turnover | 0 | 1.81 | 0 | 1.56 | 0 | |
Payables turnover | 0 | 3.74 | 0 | 3.72 | 0 | |
Inventory turnover | 0 | -2.33 | 0 | 6.37 | 0 | |
ROE | 0.02 | 0.03 | 0.03 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CARERATING.NS Frequently Asked Questions
What is CARE Ratings Limited stock symbol ?
CARE Ratings Limited is a IN stock and trading under the symbol CARERATING.NS
What is CARE Ratings Limited stock quote today ?
CARE Ratings Limited stock price is $1119.4 today.
Is CARE Ratings Limited stock public?
Yes, CARE Ratings Limited is a publicly traded company.